ArticleMolecular & cellular oncology2018

CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead.

Eldad Zacksenhaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.